Osteopore International

Osteopore is a Singapore-founded, Australia-listed regenerative medtech company that develops and commercializes 3D-printed bioresorbable implants designed to support natural bone healing. Its products use proprietary micro-structured scaffold technology, primarily based on polycaprolactone-containing biomaterials, to facilitate tissue and vascular ingrowth and then gradually resorb over time. The company has commercial products in craniofacial, neurosurgical, rhinoplasty, dental, and custom bone reconstruction applications, and is expanding into adjacent indications through collaborations and licensing. Osteopore manufactures its implants in-house and markets them through direct and distributor-led channels across Asia, Europe, Australia, and the Americas. In addition to its marketed portfolio, the company is pursuing pipeline extensions such as customized devices, surgical guides, injectable regenerative bone filler products, and other bone/tissue regeneration technologies.